post-bg-611
calendary October 28, 2022

Fluorescence in situ hybridization – FISH test

In Russia, there is a risk of disappearance of tests for genetic breakdowns and oncological diseases. According to information from some laboratories, there is a risk of stopping the so-called FISH studies. It can happen because the American manufacturer of equipment, reagents, consumables, and software Thermo Fisher Scientific left the country.

Fluorescence in situ hybridization (FISH) is a molecular cytogenetics technique that identifies a specific chromosome or part of a cell's chromosome. The FISH method can detect small changes in chromosomes that cannot be detected by conventional cytogenetic methods.

Very roughly, the principle of the FISH test can be described as follows: there is a set of DNA samples of different composition. These samples are labeled with a fluorescent label. If DNA fragments compatible with the sample are present in the patient's material, they bind, and the researcher can detect this binding using a fluorescent microscope, in which a fluorescent signal appears (a positive FISH test result). The method makes it possible to evaluate not only the presence of a fluorescent signal, but also its intensity and localization. Thus, the FISH test is not only a qualitative, but also a quantitative method.

Among the advantages of the method the possibility of using various biomaterials for research, high sensitivity, and accuracy in determining chromosomal abnormalities in tissues with low proliferative activity can be noted.

FISH tests are not so popular among genetic tests in Russia (their proportion is no more than 5 %), but recently the frequency of their use has increased. Basically, the scope of their application is the differential diagnosis of malignant diseases, primarily in the field of oncohematology.

In addition, FISH tests are also used to diagnose genetic disorders, such as infertility due to hereditary causes, as well as in prenatal diagnosis.

Currently, there are certain problems with FISH test consumables, however, leaving only Thermo Fisher Scientific will not completely block the use of this method, since many companies produce FISH test reagents, for example, Kreatech, Abbot, CytoTest.


  1. Wan TS, Ma ES. Molecular cytogenetics: an indispensable tool for cancer diagnosis. Anticancer Res. 2005 Jul-Aug;25(4):2979-83.
  2. Kolialexi A, Tsangaris GT, Kitsiou S, Kanavakis E, Mavrou A. Impact of cytogenetic and molecular cytogenetic studies on hematologic malignancies. Chang Gung Med J. 2012 Mar-Apr;35(2):96-110.
  3. Mühlmann M. Molecular cytogenetics in metaphase and interphase cells for cancer and genetic research, diagnosis and prognosis. Application in tissue sections and cell suspensions. Genet Mol Res. 2002 Jun 30;1(2):117-27.
References:
  1. https://pharmvestnik.ru/content/news/V-Rossii-mogut-ischeznut-testy-na-geneticheskie-polomki-i-onkozabolevaniya.html

More related posts

new-img-1

Control

Fine for spa resort in Yessentuki

Roszdravnadzor has imposed a fine of 130 thousand rubles on a spa resort in Yessentuki for improper storage of medical products…

03.03.2016
READ ARTICLE
new-img-2

Roszdravnadzor

Roszdravnadzor – patients’ rights

In 2015, Roszdravnadzor restored the rights of more than 460 thousand citizens to effective, accessible, and safe medical…

03.03.2016
READ ARTICLE
new-img-3

Regulation

The certification scheme for medical products hasn’t changed recently

Roszdravnadzor informs that the certification scheme for products in the Russian Federation is determined by Decree of the…

03.04.2016
READ ARTICLE
new-img-4

Control

Fines – Rostov region

In one and a half months of 2016, the Local Agency of Roszdravnadzor in Rostov Region imposed fines of the total amount of…

03.10.2016
READ ARTICLE
new-img-5

Control

Unregistered medical products

Two citizens were fined for selling unregistered medicinal products on the Internet in the Republic of Bashkortostan.

03.10.2016
READ ARTICLE
new-img-6

Control

Unscheduled inspection by roszdravnadzor

Roszdravnadzor started an unscheduled inspection of the Federal State-Funded Institution of Sverdlovsk Region Kirovgrad Central…

03.14.2016
READ ARTICLE
new-img-7

Medical Devices

International medical device regulators forum (IMDRF)

The delegation of the Federal Service for Surveillance in Healthcare headed by Mikhail Murashko, Head of Roszdravnadzor,…

03.17.2016
READ ARTICLE
new-img-8

Pharmaceuticals

Roszdravnadzor has suspended a series of the preparation “Paratsetomol-UBF”

Roszdravnadzor has suspended a series of the preparation “Paratsetomol-UBF” in which pills the metal wire was found.

05.18.2016
READ ARTICLE
new-img-9

Roszdravnadzor

Medical equipment stands idle in the Pskov region

Roszdravnadzor (RZN) statement: the expensive medical equipment for the total amount of 342 million rubles stands idle in…

05.19.2016
READ ARTICLE
new-img-10

Control

Hospital control Jewish autonomous region

Roszdravnadzor has audited the activity of the Regional Budgetary Public Health Facility “Central district hospital of Lenin”…

05.20.2016
READ ARTICLE